Steve Scala
Stock Analyst at TD Cowen
(4.46)
# 1,158
Out of 4,698 analysts
400
Total ratings
62.5%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNY Sanofi | Maintained: Hold | $57 | $44.34 | +28.57% | 26 | Aug 31, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 17,799p | 12,146p | +46.54% | 9 | Aug 31, 2026 | |
| GSK GSK plc | Maintained: Buy | $70 | $50.87 | +37.61% | 31 | Aug 25, 2026 | |
| ZTS Zoetis | Rated: Buy | $104 → $94 | $76.29 | +23.21% | 25 | Aug 25, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $32 | $24.42 | +31.04% | 18 | Aug 25, 2026 | |
| PFE Pfizer | Maintained: Hold | n/a | $28.81 | - | 44 | Aug 11, 2026 | |
| ABBV AbbVie | Maintained: Buy | $280 | $260.21 | +7.61% | 40 | Jul 31, 2026 | |
| NVS Novartis AG | Maintained: Hold | $180 | $163.09 | +10.37% | 35 | Jul 27, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $300 | $278.43 | +7.75% | 1 | Jul 13, 2026 | |
| RHHBY Roche Holding AG | Maintained: Hold | $67 | $55.22 | +21.33% | 27 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,250 | $1,159.60 | +7.80% | 47 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $120 → $137 | $152.34 | -10.07% | 31 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $10.34 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $54 | $68.09 | n/a | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $15 | $13.77 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16.60 | $9.32 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $63.88 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.22 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.95 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 96.59 → CHF 109.47 | CHF 131.32 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $47.51 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,054 | kr 301.55 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,250p → 1,790p | 1,867p | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | CHF 356.50 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €41.43 → €98.00 | €76.27 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.12 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €67.32 → €74.22 | €137.85 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $444.12 | n/a | 2 | Oct 3, 2017 |
Sanofi
Aug 31, 2026
Maintained: Hold
Price Target: $57
Current: $44.34
Upside: +28.57%
AstraZeneca PLC
Aug 31, 2026
Maintained: Buy
Price Target: 17,799p
Current: 12,146p
Upside: +46.54%
GSK plc
Aug 25, 2026
Maintained: Buy
Price Target: $70
Current: $50.87
Upside: +37.61%
Zoetis
Aug 25, 2026
Rated: Buy
Price Target: $104 → $94
Current: $76.29
Upside: +23.21%
Elanco Animal Health
Aug 25, 2026
Rated: Buy
Price Target: $32
Current: $24.42
Upside: +31.04%
Pfizer
Aug 11, 2026
Maintained: Hold
Price Target: n/a
Current: $28.81
Upside: -
AbbVie
Jul 31, 2026
Maintained: Buy
Price Target: $280
Current: $260.21
Upside: +7.61%
Novartis AG
Jul 27, 2026
Maintained: Hold
Price Target: $180
Current: $163.09
Upside: +10.37%
Johnson & Johnson
Jul 13, 2026
Maintained: Buy
Price Target: $300
Current: $278.43
Upside: +7.75%
Roche Holding AG
Apr 23, 2026
Maintained: Hold
Price Target: $67
Current: $55.22
Upside: +21.33%
Apr 2, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,159.60
Upside: +7.80%
Mar 30, 2026
Maintained: Hold
Price Target: $120 → $137
Current: $152.34
Upside: -10.07%
Aug 7, 2025
Maintained: Hold
Price Target: $9 → $8
Current: $10.34
Upside: n/a
Jul 31, 2025
Maintained: Hold
Price Target: $64 → $54
Current: $68.09
Upside: n/a
Apr 22, 2025
Maintained: Hold
Price Target: $19 → $15
Current: $13.77
Upside: n/a
Feb 21, 2025
Maintained: Hold
Price Target: $16.60
Current: $9.32
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $63.88
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $5.95
Upside: n/a
Nov 11, 2024
Maintained: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: CHF 131.32
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $47.51
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: kr 1,054
Current: kr 301.55
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: 2,250p → 1,790p
Current: 1,867p
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: CHF 356.50
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €41.43 → €98.00
Current: €76.27
Upside: n/a
Jun 24, 2021
Maintained: Buy
Price Target: n/a
Current: $5.12
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €67.32 → €74.22
Current: €137.85
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $444.12
Upside: n/a